New insight into brain disorders

	Tweet

New findings will help in the understanding of how memories are laid down and what goes wrong in brain disorders

The function of an enzyme in the brain – strongly linked to a number of major brain diseases such as Alzheimer’s, schizophrenia and bi-polar disorder – has been identified for the first time by researchers at the University of Bristol, UK.

These findings, published today in Neuron, will help in the understanding of how memories are laid down and what goes wrong in these disorders.

The research showed how controlling the activity of glycogen synthase kinase-3 (GSK3) might prevent a memory being erased by improving the strength of connections between neurons in the brain, thus allowing better consolidation of new information.

Professor Collingridge from the University of Bristol said: “While GSK3 has previously been implicated in major neurological disorders, until now its role in normal neuronal function has been largely unknown. Our new understanding will help pharmaceutical companies develop drugs to inhibit it when things go wrong.”

Professor Graham Collingridge and his team, with colleagues from the University of British Columbia, revealed that the activity of GSK3 facilitates a form of ‘cross-talk’ between the two major forms of synaptic plasticity in the brain.

Synaptic plasticity is the strength of a connection between neurons and forms the basis of learning and memory.

University of Bristol

RELATED STORIES:
Teenage stress has implications for adult health   Thalidomide may slow Lou Gehrig’s disease   Dyslexia varies across language barriers   Misdiagnosis of disorders of consciousness still commonplace   Grumpy British bosses need more sleep - study   Smoking Increase Risk of age-related macular degeneration   Stress may have only small impact on weight   Scientists find brain function most important to maths ability   Vitamin B6 may cut risk of Parkinson’s disease   New Treatment for Stroke Works up to a Day After Symptoms Start   Major biomarker candidates for Alzheimer’s disease explored   A coffee with your doughnut could protect against Alzheimer’s disease

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]